The emerging therapy of the medication represents a major advance in the care of diabetes mellitus type 2. Distinct from existing medications, tirzepatide targets two pathways – glucagon-like peptide-1 (GLP-1) and https://tirzepatidepeptide338823.dailyblogzz.com/42497749/tirzepatide-peptide-a-new-frontier-in-diabetes-treatment